Loomis Sayles & CO L P Novartis Ag Transaction History
Loomis Sayles & CO L P
- $77.3 Billion
- Q2 2025
A detailed history of Loomis Sayles & CO L P transactions in Novartis Ag stock. As of the latest transaction made, Loomis Sayles & CO L P holds 5,581,576 shares of NVS stock, worth $739 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
5,581,576
Previous 5,503,093
1.43%
Holding current value
$739 Million
Previous $613 Million
10.1%
% of portfolio
0.87%
Previous 0.89%
Shares
33 transactions
Others Institutions Holding NVS
# of Institutions
1,562Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.41 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.38 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.2 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$1 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$943 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $285B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...